[1] WANG J, LU FM, ZHUANG H.The anaIysis on the epidemic trend of viral hepatitis in China during recent 10 years (2002-2011) [J].Chin J Hepatol, 2013, 21 (8) :561-564. (in Chinese) 王杰, 鲁凤民, 庄辉.我国2002-2011年病毒性肝炎的流行趋势[J].中华肝脏病杂志, 2013, 21 (8) :561-564.
|
[2]HAN GR, XU CL, ZHAO W, et al.Management of chronic hepatitis B in pregnancy[J].World J Gastroenterol, 2012, 18 (33) :4517-4521.
|
[3]SINHA S, KUMAR M.Pregnancy and chronic hepatitis B virus infection[J].Hepatol Res, 2010, 40 (1) :31-48.
|
[4]JOSHI D, JAMES A, QUAGLIA A, et al.Liver disease in pregnancy[J].Lancet, 2010, 375 (9714) :594-605.
|
[5]AHMED KT, ALMASHHRAWI AA, RAHMAN RN, et al.Liver diseases in pregnancy:diseases unique to pregnancy[J].World J Gastroenterol, 2013, 19 (43) :7639-7646.
|
[6] Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association.Clinical guidelines for prevention of mother-to-child transmission of hepatitis B virus (1st version) [J].Chin J Obstetr Gynecol, 2013, 48 (2) :151-154. (in Chinese) 中华医学会妇产科学分会产科学组.乙型肝炎病毒母婴传播预防临床指南 (第一版) [J].中华妇产科杂志, 2013, 48 (2) :151-154.
|
[7]LAMPERTICO P, VIGAN M, COLOMBO M.Why do I treat HBeAg-negative chronic hepatitis B patients with pegylated interferon?[J].Liver Int, 2013, 33 (Suppl 1) :157-163.
|
[8] WAN MB, WENG XH.Expert advices on interferon therapy for chronic hepatitis B (updated in 2010) [J].Chin J Infect Dis, 2010, 28 (4) :193-200. (in Chinese) 万谟彬, 翁心华.干扰素治疗慢性乙型肝炎专家建议 (2010年更新) [J].中华传染病杂志, 2010, 28 (4) :193-200.
|
[9] Chinese Society of Hepatolgy and Chinese Society of Infecttious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].Chin J Infect Dis, 2011, 39 (2) :65-80. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010年) [J].中华传染病杂志, 2011, 39 (2) :65-80.
|
[10]GILES ML, VISVANATHAN K, SASADEUSZ J.Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding[J].Antivir Ther, 2011, 16 (5) :621-628.
|
[11]GILES ML, VISVANATHAN K, LEWIN SR, et al.Chronic hepatitis B infection and pregnancy[J].Obstet Gynecol Surv, 2012, 67 (1) :37-44.
|
[12]POL S, COROUGE M, FONTAINE H.Hepatitis B virus infection and pregnancy[J].Clin Res Hepatol Gastroenterol, 2011, 35 (10) :618-622.
|
[13]PAN CQ, DUAN ZP, BHAMIDIMARRI KR, et al.An algorithm for risk assessment and Intervention of mother to child transmission of Hepatitis B virus[J].Clin Gastroenterol Hepatol, 2012, 10 (5) :452-459.
|
[14]HORVTH G.Interdisciplinary aspects of and new drugs for chronic hepatitis B[J].Orv Hetil, 2013, 154 (29) :1142-1150.
|
[15]YI W, LIU M, CAI HD.Safety of lamivudine treatment for chronic hepatitis B in early pregnancy[J].World J Gastroenterol, 2012, 18 (45) :6645-6650.
|
[16]HAN L, ZHANG HW, XIE JX, et al.A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus[J].World J Gastroenterol, 2011, 17 (38) :4321-4333.
|
[17]FAN YL, JIANG XN, WAN J, et al.Efficacy and safety of telbivudine in the perinatal transmission of hepatitis B virus[J].J Med Res, 2013, 42 (9) :103-106. (in Chinese) 范玲燕, 姜秀浓, 万炯, 等.替比夫定对乙型肝炎病毒母婴传播的阻断作用及安全性分析[J].医学研究杂志, 2013, 42 (9) :103-106.
|
[18]JIANG XN, SHI KS, LI DZ, et al.Efficacy and safety of Telbivudine using in pregnant patients with chronic HBV infection[J].J Med Res, 2012, 41 (7) :172-174. (in Chinese) 姜秀浓, 施凯舜, 李德周, 等.替比夫定治疗慢性HBV感染孕妇的疗效和安全性观察[J].医学研究杂志, 2012, 41 (7) :172-174.
|
[19]HAN GR, JIANG HX, WNAG GJ, et al.Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus[J].Chin J Hepatol, 2012, 20 (3) :201-205. (in Chinese) 韩国荣, 江红秀, 王根菊, 等.替比夫定对乙型肝炎病毒高载量孕妇母婴传播的阻断效果及其安全性[J].中华肝脏病杂志, 2012, 20 (3) :201-205.
|
[20]HAN GR, CAO MK, ZHAO W, et al.A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection[J].J Hepatol, 2011, 55 (6) :1215-1221.
|
[21]BUCHANAN C, TRAN TT.Management of chronic hepatitis B in pregnancy[J].Clin Liver Dis, 2010, 14 (3) :495-504.
|
[22]YOGESWARAN K, FUNG SK.Chronic hepatitis B in pregnancy:unique challenges and opportunities[J].Korean J Hepatol, 2011, 17 (1) :1-8.
|
[23]WANG HH, WANG ZP.A Meta analysis:mother to infant transmission of hepatitis B virus via different combined immunoprophylaxis delivery modes[J].Chin J Prevent Med, 2010, 44 (3) :221-223. (in Chinese) 王慧华, 王正平.联合免疫婴儿的娩出方式对乙型肝炎病毒母婴传播影响的Meta分析[J].中华预防医学杂志, 2010, 44 (3) :221-223.
|
[24] YU MM, JIANG Q, GU X, et al.Correlation between vertical transmission of hepatitis B virus and the expression of HBsAg in ovarian follicles and placenta[J].PLoS One, 2013, 8 (1) :e54246.
|
[25] DOU L, SUN H.Research advaces in influencing factors for no (weak) response to hepatitis B vaccine in Children[J].Int J Viron, 2012, 19 (1) :42-44. (in Chinese) 窦蕾, 孙荷.儿童接种乙肝疫苗后无 (弱) 应答影响因素的研究进展[J].国际病毒学杂志, 2012, 19 (1) :42-44.
|
[26]BOOT HJ, HAHNS, CREMER J, et al.Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination[J].J Viral Hepat, 2010, 17 (12) :872-878.
|
[27]KUMAR A.Hepatitis B virus infection and pregnancy:a practical approach[J].Indian J Gastroenterol, 2012, 31 (2) :43-54.
|
[28]PARK NH, CHUNG YH, LEE HS.Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period[J].Intervirology, 2010, 53 (1) :20-28.
|
[29]PANDE C, SARIN SK, PATRA S, et al.Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies:a randomized controlled trial[J].J Viral Hepat, 2013, 20 (11) :801-810.
|
[30] CHEN XR, CHEN J, WEN J, et al.Breastfeeding is not a risk factor for mother-to-child transmission of Hepatitis B virus[J].PLoS One, 2013, 8 (1) :e55303.
|
[31]SHI Z, YANG Y, WANG H, et al.Breastfeeding of newborns by mothers carrying hepatitis B virus:a meta analysis and systematic review[J].Arch Pediatr Adolesc Med, 2011, 165 (9) :837-846.
|